pede4dPharmacological phosphodiesterase 4D (PDE4D) inhibition shows therapeutic potential to restore memory function in Alzheimer's disease (AD), but will likely evoke adverse side effects. AsThe N-terminus conserved domain UCR1 and UCR2 mentioned above play an important role in dimerization of PDE4D and in the regulation of the catalytic domain [13],